Candriam SCA’s Repare Therapeutics RPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-50,001
Closed -$529K 686
2023
Q2
$529K Buy
+50,001
New +$529K ﹤0.01% 675